28.2 C
Philippines
Monday, April 22, 2024

1:06 AM

28.2 C
Philippines
Monday, April 22, 2024

1:06 AM

Ivermectin not recommended to treat COVID-19, says health exec

CAGAYAN DE ORO CITY (PIA)—Dr. Jose R. Llacuna Jr, regional director of the Department of Health (DOH)-10, reiterated that human use of Ivermectin formulated for animals is not recommended.

He said the DOH does not recommend Ivermectin to be used as a remedy or treat COVID-19 due to insufficient scientific evidence.

Llacuna said based on the Philippine COVID-19 Living CPG reviewers of the UP-NIH ICE and Consensus panel representative of DOH-FDA, PMA, PCP, PAFP, POGS, PCEM, PSGIM, PCCP, PSPHP, and PSMID official statement early this year—regarding the use of Ivermectin for treatment of COVID 19— the said drug did not significantly lower the risk of mortality in individuals with mild to severe COVID-19.

The study says it is not associated with a definite benefit in terms of clinical improvement at day six to ten, clinical deterioration, and the requirement for mechanical breathing. It did not substantially reduce the duration of hospitalization and the time to resolution of symptoms, and the rate of hospitalization discharge at day ten to fourteen did not differ significantly between the Ivermectin group and the standard of care or placebo group.

Further studies of the Cochrane research group also showed that Ivermectin did not reduce deaths, needs for mechanical ventilation or supplemental oxygen, or unwanted events in patients. Cochrane’s study also indicates that the use of Ivermectin did not increase or reduce negative COVID-19 tests; there is no difference in the days of hospitalization; there are no improvements in outpatients’ condition; and it did not prevent confirmed COVID-19.

Llacuna described Cochrane as a global independent network of researchers, professionals, patients, caregivers, and people interested in health.

He clarified that the DOH and Philippine Food and Drug Administration (FDA) has issued an advisory to apprise the public that the registered Ivermectin veterinary products are only approved for use in prevention of heartworm disease and treatment of internal and external parasites in certain animal species. The advisory, he said, specified that Ivermectin is not approved by the FDA for treatment of any viral infection.   

Llacuna explained that the said drug may be used as an anti-parasitic or off-label only in a strict clinical trial setting such as the Department of Science and Technology–Philippine Council for Health Research and Development.

The DOH 10 regional director further urges the stakeholders to strengthen their COVID-19 response through evidence-based Prevention, Detection, Isolation, Treatment, and Reintegration strategies, including the vaccination rollout of the government. (JAKA/PIA-10)